PROSCAR DIN 02010909
Health Canada record
| Active ingredient(s) | FINASTERIDE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G04CB01 FINASTERIDE |
| Original market date | 31-Dec-1992 |
| Current status date | 19-Jul-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Organon Canada Inc. — licence 3-002674, currently licensed, last inspection rating C (2025-11-06).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FINASTERIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02355043 | ACH-FINASTERIDE | ACCORD HEALTHCARE INC | Tablet | FINASTERIDE 5 MG | Marketed |
| 02405814 | AURO-FINASTERIDE | AURO PHARMA INC | Tablet | FINASTERIDE 5 MG | Marketed |
| 02428148 | AURO-FINASTERIDE 1MG | AURO PHARMA INC | Tablet | FINASTERIDE 1 MG | Marketed |
| 02527847 | BIO-FINASTERIDE | BIOMED PHARMA | Tablet | FINASTERIDE 5 MG | Marketed |
| 02447568 | FINASTERIDE | SIVEM PHARMACEUTICALS ULC | Tablet | FINASTERIDE 1 MG | Marketed |
| 02447541 | FINASTERIDE | SIVEM PHARMACEUTICALS ULC | Tablet | FINASTERIDE 5 MG | Marketed |
| 02445085 | FINASTERIDE | SANIS HEALTH INC | Tablet | FINASTERIDE 1 MG | Marketed |
| 02445077 | FINASTERIDE | SANIS HEALTH INC | Tablet | FINASTERIDE 5 MG | Marketed |
| 02554461 | JAMP FINASTERIDE TABLETS | JAMP PHARMA CORPORATION | Tablet | FINASTERIDE 1 MG | Marketed |
| 02537427 | MINT-FINASTERIDE | MINT PHARMACEUTICALS INC | Tablet | FINASTERIDE 1 MG | Marketed |
| 02389878 | MINT-FINASTERIDE | MINT PHARMACEUTICALS INC | Tablet | FINASTERIDE 5 MG | Marketed |
| 02535637 | NRA-FINASTERIDE | NORA PHARMA INC | Tablet | FINASTERIDE 5 MG | Marketed |
| 02310112 | PMS-FINASTERIDE | PHARMASCIENCE INC | Tablet | FINASTERIDE 5 MG | Marketed |
| 02320169 | PMS-FINASTERIDE | PHARMASCIENCE INC | Tablet | FINASTERIDE 1 MG | Marketed |
| 02350270 | PRO-FINASTERIDE | PRO DOC LIMITEE | Tablet | FINASTERIDE 5 MG | Marketed |
| 02238213 | PROPECIA | ORGANON CANADA INC. | Tablet | FINASTERIDE 1 MG | Marketed |
| 02549204 | RIVA-FINASTERIDE | LABORATOIRE RIVA INC. | Tablet | FINASTERIDE 1 MG | Approved |
| 02455013 | RIVA-FINASTERIDE | LABORATOIRE RIVA INC. | Tablet | FINASTERIDE 5 MG | Marketed |
| 02339471 | SANDOZ FINASTERIDE A | SANDOZ CANADA INCORPORATED | Tablet | FINASTERIDE 1 MG | Marketed |
| 02348500 | TEVA-FINASTERIDE | TEVA CANADA LIMITED | Tablet | FINASTERIDE 5 MG | Marketed |
| 02401142 | ACCEL-FINASTERIDE TABLETS USP | ACCEL PHARMA INC | Tablet | FINASTERIDE 5 MG | Cancelled Pre Market |
| 02354462 | ACT FINASTERIDE | ACTAVIS PHARMA COMPANY | Tablet | FINASTERIDE 5 MG | Cancelled Post Market |
| 02374404 | AG-FINASTERIDE | ANGITA PHARMA INC. | Tablet | FINASTERIDE 5 MG | Dormant |
| 02365383 | APO-FINASTERIDE | APOTEX INC | Tablet | FINASTERIDE 5 MG | Dormant |
| 02376709 | DOM-FINASTERIDE | DOMINION PHARMACAL | Tablet | FINASTERIDE 5 MG | Cancelled Post Market |
| 02348888 | FINASTERIDE | MELIAPHARM INC | Tablet | FINASTERIDE 5 MG | Cancelled Post Market |
| 02357224 | JAMP-FINASTERIDE | JAMP PHARMA CORPORATION | Tablet | FINASTERIDE 5 MG | Dormant |
| 02522489 | M-FINASTERIDE | MANTRA PHARMA INC | Tablet | FINASTERIDE 5 MG | Dormant |
| 02356058 | MYLAN-FINASTERIDE | MYLAN PHARMACEUTICALS ULC | Tablet | FINASTERIDE 5 MG | Cancelled Post Market |
| 02392631 | MYLAN-FINASTERIDE HG | MYLAN PHARMACEUTICALS ULC | Tablet | FINASTERIDE 1 MG | Cancelled Post Market |
| 02376113 | NTP-FINASTERIDE | TEVA CANADA LIMITED | Tablet | FINASTERIDE 5 MG | Cancelled Pre Market |
| 02371820 | RAN-FINASTERIDE | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | FINASTERIDE 5 MG | Cancelled Post Market |
| 02306905 | RATIO-FINASTERIDE | TEVA CANADA LIMITED | Tablet | FINASTERIDE 5 MG | Cancelled Post Market |
| 02322579 | SANDOZ FINASTERIDE | SANDOZ CANADA INCORPORATED | Tablet | FINASTERIDE 5 MG | Cancelled Post Market |
| 02428741 | VAN-FINASTERIDE | VANC PHARMACEUTICALS INC | Tablet | FINASTERIDE 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25708 | 2021-04-21 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 7001 | 2005-06-02 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for FINASTERIDE
7 valid EDQM Certificates of Suitability from 7 holders. 10 active FDA Drug Master Files.
Request a quote for PROSCAR